CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Clinical trial NCT07347418 · RECRUITING

Trial details

NCT number: NCT07347418
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Acute Myeloid Leukemia (AML)Relapsed Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome AML (Acute Myeloid Leukemia)

Start date: 2026-06-01
Primary completion: 2029-06-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.